Personalized circulating tumor DNA analysis to detect residual disease after neoadjuvant therapy in breast cancer - McDonald, Bradon R; Contente-Cuomo, Tania; Sammut, Stephen-John; Odenheimer-Bergman, Ahuva; Ernst, Brenda; Perdigones, Nieves; Chin, Suet-Feung; Farooq, Maria; Mejia, Rosa; Cronin, Patricia A; Anderson, Karen S; Kosiorek, Heidi E; et al. (Science translational medicine, 2019)
Keywords: Biological Assay; Breast Neoplasms - blood; Breast Neoplasms - drug therapy; Breast Neoplasms - genetics; Circulating Tumor DNA - analysis; Circulating Tumor DNA - blood; Circulating Tumor DNA - genetics; Female; Humans; Mutation - genetics; Neoadjuvant Therapy; Neoplasm Staging; Neoplasm, Residual - blood; Neoplasm, Residual - drug therapy; Neoplasm, Residual - genetics; Reference Standards; ROC Curve; Sequence Analysis, DNA